Recent Developments on the Synthesis and Bioactivity of Ilamycins/Rufomycins and Cyclomarins, Marine Cyclopeptides That Demonstrate Anti-Malaria and Anti-Tuberculosis Activity.

Antimalarials / pharmacology Antitubercular Agents / pharmacology Aquatic Organisms Humans Mycobacterium tuberculosis / drug effects Oligopeptides / pharmacology Peptides, Cyclic / pharmacology Phytotherapy Plasmodium falciparum / drug effects Streptomyces
biosynthesis cyclomarins cyclopeptides ilamycins malaria natural products rufomycins total synthesis tuberculosis

Journal

Marine drugs
ISSN: 1660-3397
Titre abrégé: Mar Drugs
Pays: Switzerland
ID NLM: 101213729

Informations de publication

Date de publication:
03 Aug 2021
Historique:
received: 20 07 2021
revised: 29 07 2021
accepted: 30 07 2021
entrez: 26 8 2021
pubmed: 27 8 2021
medline: 12 1 2022
Statut: epublish

Résumé

Ilamycins/rufomycins and cyclomarins are marine cycloheptapeptides containing unusual amino acids. Produced by

Identifiants

DOI: 10.3390/md19080446 PMID: 34436284 PMC: PMC8401383
pubmed: 34436284
pii: md19080446
doi: 10.3390/md19080446
pmc: PMC8401383
pii:
doi:

Substances chimiques

Antimalarials 0
Antitubercular Agents 0
Oligopeptides 0
Peptides, Cyclic 0
rufomycin 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Mar Drugs. 2020 Apr 17;18(4):
pubmed: 32316457
Org Lett. 2018 Oct 5;20(19):6166-6169
pubmed: 30252492
J Am Chem Soc. 2008 Apr 2;130(13):4507-16
pubmed: 18331040
J Hematol Oncol. 2019 Jun 11;12(1):60
pubmed: 31186039
FEBS J. 2008 Dec;275(24):6149-58
pubmed: 19016865
ACS Infect Dis. 2019 Jun 14;5(6):829-840
pubmed: 30990022
Chem Rev. 2014 Nov 26;114(22):11138-63
pubmed: 25014712
J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):455-62
pubmed: 22126739
Chembiochem. 2015 Nov;16(17):2433-6
pubmed: 26472355
Org Biomol Chem. 2015 Sep 21;13(35):9267-75
pubmed: 26229033
Antimicrob Agents Chemother. 2019 Feb 26;63(3):
pubmed: 30602512
Org Lett. 2013 Jun 7;15(11):2798-801
pubmed: 23714013
Chemistry. 2019 Jul 2;25(37):8894-8902
pubmed: 31012978
J Ind Microbiol Biotechnol. 2016 Mar;43(2-3):205-12
pubmed: 26586403
J Antimicrob Chemother. 2012 Apr;67(4):810-8
pubmed: 22290346
Nat Prod Rep. 2020 Feb 26;37(2):175-223
pubmed: 32025684
Future Microbiol. 2020 Jun;15:703-708
pubmed: 32648783
J Biol Chem. 2018 Jun 1;293(22):8379-8393
pubmed: 29632076
Mar Drugs. 2020 Dec 04;18(12):
pubmed: 33291602
J Nat Prod. 2012 Mar 23;75(3):311-35
pubmed: 22316239
J Antibiot (Tokyo). 1964 May;17:129-31
pubmed: 14171220
Angew Chem Int Ed Engl. 2011 Jun 20;50(26):5889-91
pubmed: 21563281
J Biol Chem. 2013 Oct 25;288(43):30883-91
pubmed: 24022489
Chemistry. 2002 Apr 15;8(8):1850-5
pubmed: 12007095
Org Biomol Chem. 2018 Dec 19;17(1):88-102
pubmed: 30520486
J Antibiot (Tokyo). 1963 Sep;16:211-2
pubmed: 14066397
J Antibiot (Tokyo). 1962 Jan;15:46-8
pubmed: 14039629
Chemistry. 2009 Jul 20;15(29):7192-202
pubmed: 19544505
J Antibiot (Tokyo). 1964 Nov;17:264-5
pubmed: 14236207
Nat Rev Drug Discov. 2013 May;12(5):388-404
pubmed: 23629506
J Nat Prod. 2021 Apr 23;84(4):1056-1066
pubmed: 33621083
Angew Chem Int Ed Engl. 2010 Jun 21;49(27):4665-8
pubmed: 20480475
Mol Microbiol. 2014 Aug;93(4):617-28
pubmed: 24976069
Angew Chem Int Ed Engl. 2009;48(38):7025-9
pubmed: 19701955
J Antibiot (Tokyo). 2017 Nov 01;:
pubmed: 29089593
FEBS Lett. 1971 Sep 15;17(1):145-148
pubmed: 11946017
J Nat Prod. 2020 Mar 27;83(3):657-667
pubmed: 32031795
Nat Prod Rep. 2021 Mar 4;38(2):362-413
pubmed: 33570537
Molecules. 2021 Jan 05;26(1):
pubmed: 33466486
Org Biomol Chem. 2016 Jul 7;14(25):6036-54
pubmed: 27241518
J Nat Prod. 2020 May 22;83(5):1646-1657
pubmed: 32324401
J Nat Prod. 2010 Mar 26;73(3):373-7
pubmed: 20055491
Chem Pharm Bull (Tokyo). 1964 Nov;12(11):1390-2
pubmed: 5888651
Org Lett. 2004 Aug 5;6(16):2721-4
pubmed: 15281753
J Biol Chem. 2017 Sep 22;292(38):15859-15869
pubmed: 28774961
J Org Chem. 2006 Mar 3;71(5):2026-36
pubmed: 16496990
J Antibiot (Tokyo). 2020 Aug;73(8):504-525
pubmed: 32507851
Org Lett. 2016 Jan 15;18(2):204-7
pubmed: 26699807
Cell Chem Biol. 2019 Aug 15;26(8):1169-1179.e4
pubmed: 31204287
J Antibiot (Tokyo). 1963 Nov;16:246
pubmed: 14084123
J Antibiot (Tokyo). 1965 May;18:135-6
pubmed: 14336172
Org Lett. 2008 Jun 5;10(11):2175-8
pubmed: 18459798
Nat Commun. 2017 Aug 30;8(1):391
pubmed: 28855504
Org Biomol Chem. 2016 Jul 7;14(25):6055-64
pubmed: 27241664
J Am Chem Soc. 2005 Aug 17;127(32):11505-15
pubmed: 16089481

Auteurs

Uli Kazmaier (U)

Organic Chemistry, Saarland University, Campus Building C4.2, 66123 Saarbrücken, Germany.
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)-Helmholtz Centre for Infection Research (HZI), Campus Building E8 1, 66123 Saarbrücken, Germany.
ORCID: 0000-0001-9756-0589

Lukas Junk (L)

Organic Chemistry, Saarland University, Campus Building C4.2, 66123 Saarbrücken, Germany.
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)-Helmholtz Centre for Infection Research (HZI), Campus Building E8 1, 66123 Saarbrücken, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antiparasitaires › Antiprotozoaires › Antipaludiques › Recent Developments on the Synthesis and...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Antituberculeux › Recent Developments on the Synthesis and...
questionsmedicales.fr › Phénomènes biologiques › Phénomènes écologiques et environnementaux › Eaux salées › Eau de mer › Organismes aquatiques › Recent Developments on the Synthesis and...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Recent Developments on the Synthesis and...
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Bâtonnets à Gram positif › Bâtonnets asporogènes à Gram positif › Bâtonnets asporogènes réguliers à Gram positif › Mycobacteriaceae › Mycobacterium › Mycobacterium tuberculosis › Recent Developments on the Synthesis and...
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Oligopeptides › Recent Developments on the Synthesis and...
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Peptides cycliques › Recent Developments on the Synthesis and...
questionsmedicales.fr › Thérapeutique › Thérapies complémentaires › Phytothérapie › Recent Developments on the Synthesis and...
questionsmedicales.fr › Eucaryotes › Alveolata › Apicomplexa › Haemosporida › Plasmodium › Plasmodium falciparum › Recent Developments on the Synthesis and...
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Bâtonnets à Gram positif › Bâtonnets sporulés à Gram positif › Streptomycetaceae › Streptomyces › Recent Developments on the Synthesis and...